Caesarean Delivery Complications Explained: Why the Supreme Concern Over Maternal Health, C-Sections, and Oxytocin Matters in India

Rajasthan Maternal Health Crisis Raises Fresh Questions About C-Section Safety and Oxytocin Use

A series of maternal health emergencies in Rajasthan has once again brought the safety of Caesarean deliveries (C-sections), the quality of essential medicines, and India's emergency maternal healthcare system under the national spotlight.

On June 20, eight women who underwent Caesarean deliveries at the District Government Hospital in Paota, Jodhpur, reportedly fell ill shortly after surgery, triggering a fresh investigation into possible medical complications. The incident follows several maternal deaths reported in recent months from Kota, Bikaner, and Jodhpur, prompting health authorities to examine whether substandard or counterfeit oxytocin injections played a role in the tragedies.

Initial investigations into some of the earlier cases suggested that certain batches of oxytocin—a life-saving medicine routinely administered during childbirth—may have lacked the required active pharmaceutical ingredient. Although investigations are continuing and authorities are verifying the findings, the incidents have reignited concerns about maternal healthcare, medicine quality, hospital preparedness, and patient safety in India.

Beyond the immediate investigation, the events have also highlighted broader public health questions:

• How safe are Caesarean deliveries?

• Why is oxytocin considered essential during childbirth?

• What happens if the medicine is ineffective or substandard?

• What are the most common complications after a C-section?

• How is India strengthening drug quality monitoring?

Understanding these issues is essential because Caesarean sections are among the most frequently performed surgical procedures worldwide and play a critical role in reducing maternal and newborn deaths when medically indicated.

What Is a Caesarean Section (C-Section)?

A Caesarean section, commonly called a C-section, is a surgical procedure in which a baby is delivered through carefully made incisions in the mother's abdomen and uterus instead of through vaginal birth.

Doctors recommend a Caesarean delivery when a normal vaginal birth may pose significant risks to the mother, the baby, or both. While many women plan for a vaginal delivery, unforeseen medical complications during pregnancy or labour may require an emergency Caesarean section to protect lives.

Today, C-sections have become an indispensable component of modern obstetric care. According to the World Health Organization (WHO), Caesarean delivery can be life-saving when medically necessary for conditions such as obstructed labour, severe fetal distress, placenta previa, uterine rupture, or certain high-risk pregnancies.

However, experts also caution that unnecessary Caesarean deliveries should be avoided because, like any major surgery, they carry inherent risks that require careful management.

Why Are Caesarean Deliveries Performed?

Doctors may recommend a Caesarean section under several medical circumstances.

1. Fetal Distress

If continuous monitoring indicates that the baby is not receiving adequate oxygen during labour, an emergency C-section may be performed to prevent serious complications.

2. Obstructed or Prolonged Labour

Sometimes labour does not progress despite strong contractions. If the cervix stops dilating or the baby's head cannot safely pass through the birth canal, surgery becomes the safest option.

3. Placenta-Related Complications

Conditions such as placenta previa or placental abruption can cause severe bleeding and require immediate surgical delivery.

4. Multiple Pregnancies

Women carrying twins, triplets, or higher-order multiple pregnancies often require Caesarean delivery depending on fetal positioning and maternal health.

5. Previous Caesarean Delivery

Although many women successfully undergo vaginal birth after Caesarean (VBAC), others may require repeat surgery depending on the condition of the uterus and pregnancy-related risks.

6. Maternal Medical Conditions

High blood pressure, severe pre-eclampsia, uncontrolled diabetes, cardiac disease, certain infections, or other serious medical conditions may make Caesarean delivery the safer option.

Are Caesarean Deliveries Safe?

Modern surgical techniques, improved anaesthesia, advanced antibiotics, and better postoperative care have made Caesarean sections significantly safer than they were decades ago.

Every day, thousands of women across India safely deliver healthy babies through C-sections.

For many mothers and newborns, the procedure is genuinely life-saving.

Nevertheless, a Caesarean section remains major abdominal surgery.

Unlike vaginal delivery, surgery involves:

• abdominal incision,

• uterine incision,

• anaesthesia,

• longer recovery,

• greater blood loss,

• higher infection risk,

• increased monitoring after delivery.

Consequently, women undergoing Caesarean delivery require careful observation before, during, and after surgery.

Understanding the Most Common Complications After a Caesarean Section

Although the majority of women recover without major problems, complications can occur during surgery, immediately afterward, or even several weeks following delivery.

Medical experts broadly classify these complications into intraoperative, early postoperative, and delayed complications.

1. Infection Is the Most Common Post-Cesarean Complication

One of the leading complications after Caesarean delivery is infection.

Since surgery involves opening the abdominal wall and uterus, bacteria can sometimes enter the surgical site despite strict sterilisation procedures.

Infections may develop in:

• the skin incision,

• deeper surgical tissues,

• the uterus,

• the urinary bladder,

• surrounding pelvic organs.

Women experiencing infection may develop symptoms such as:

• fever,

• increasing abdominal pain,

• redness around stitches,

• swelling,

• pus discharge,

• foul-smelling vaginal discharge,

• delayed wound healing.

If detected early, most infections respond well to antibiotics and proper wound care. However, untreated infections can become serious and may require additional surgical intervention.

2. Heavy Bleeding (Postpartum Haemorrhage)

Among all childbirth-related emergencies, postpartum haemorrhage remains one of the leading causes of maternal deaths worldwide.

A Caesarean section naturally involves greater blood loss than vaginal delivery because surgery requires incisions through highly vascular tissues.

Normally, doctors carefully control bleeding throughout the operation.

However, complications can sometimes lead to excessive blood loss.

Severe haemorrhage may require:

• emergency medications,

• blood transfusions,

• intensive monitoring,

• repeat surgery,

• critical care support.

Prompt recognition and treatment are essential because excessive bleeding can rapidly become life-threatening.

3. Anaesthesia-Related Complications

During a Caesarean delivery, women typically receive one of three forms of anaesthesia:

• spinal anaesthesia,

• epidural anaesthesia,

• general anaesthesia.

These medicines are generally safe when administered by trained anaesthesiologists.

Nevertheless, some patients may experience complications such as:

• sudden fall in blood pressure,

• nausea,

• vomiting,

• severe headache,

• breathing difficulty,

• allergic reactions,

• prolonged numbness,

• dizziness.

Hospitals therefore continuously monitor heart rate, blood pressure, oxygen levels, and breathing throughout the procedure.

4. Blood Clot Formation

Following any major surgery, patients face an increased risk of developing blood clots, particularly in the deep veins of the legs.

This condition, known as Deep Vein Thrombosis (DVT), can become dangerous if the clot travels to the lungs, causing a pulmonary embolism.

To minimise this risk, doctors encourage:

• early movement after surgery,

• adequate hydration,

• compression stockings for high-risk patients,

• blood-thinning medications when clinically indicated.

5. Injury to Nearby Organs

Although uncommon, nearby organs may occasionally be injured during surgery.

These include:

• urinary bladder,

• ureters,

• intestines,

• blood vessels.

Such complications are generally recognised during surgery and repaired immediately by experienced surgical teams.

Recovery After a Caesarean Delivery

Recovery following a Caesarean section usually takes longer than recovery after vaginal birth.

Most women remain in hospital for several days while doctors monitor:

• wound healing,

• bleeding,

• blood pressure,

• infection,

• pain control,

• breastfeeding,

• newborn health.

Even after discharge, complete healing may require several weeks.

Doctors usually advise mothers to:

• avoid lifting heavy objects,

• maintain proper wound hygiene,

• attend scheduled follow-up visits,

• watch for warning signs,

• seek immediate medical care if fever, severe pain, heavy bleeding, or wound discharge develops.

Why Maternal Health Remains a Public Health Priority in India

India has made significant progress in reducing maternal mortality over the past two decades through improved institutional deliveries, expanded healthcare infrastructure, better antenatal care, and increased access to skilled birth attendants.

However, maternal deaths continue to occur due to preventable factors such as:

• delayed emergency treatment,

• postpartum haemorrhage,

• infections,

• hypertensive disorders,

• inadequate access to quality healthcare,

• medicine quality issues,

• delayed referral systems.

The recent incidents reported from Rajasthan have once again highlighted the importance of ensuring not only safe surgical procedures but also the availability of high-quality medicines, trained healthcare professionals, effective emergency protocols, and rigorous regulatory oversight.

As investigations continue into the reported maternal complications, public attention has increasingly turned toward one medicine that plays a crucial role in childbirth—oxytocin. Understanding how this drug works, why it is routinely administered during Caesarean deliveries, and how counterfeit or substandard supplies can endanger lives is essential to understanding the wider issues raised by the Rajasthan cases.

Why Oxytocin Is Essential During Childbirth: Understanding Its Role in Caesarean Deliveries, Postpartum Haemorrhage, and the Rajasthan Maternal Death Investigation

The recent maternal health incidents reported from Rajasthan have placed one medicine at the centre of public discussion—oxytocin.

Initial investigations into maternal deaths reported from Kota, Bikaner, and Jodhpur suggested that certain batches of oxytocin used during childbirth may have been substandard or counterfeit, allegedly lacking the required active pharmaceutical ingredient. Authorities are continuing their investigations to determine the exact cause and establish accountability.

The allegations have raised serious concerns because oxytocin is considered one of the most important medicines used during childbirth. The World Health Organization (WHO) includes oxytocin on its Model List of Essential Medicines, recognising it as the first-line medicine for preventing and treating postpartum haemorrhage—the leading cause of maternal deaths worldwide.

To understand why the Rajasthan investigation has attracted national attention, it is important to understand how oxytocin works and why doctors routinely administer it during Caesarean deliveries.

What Is Oxytocin?

Oxytocin is a naturally occurring hormone produced by the pituitary gland, located at the base of the brain.

Often referred to as the "love hormone" or "bonding hormone," oxytocin plays an essential role in several physiological processes, including:

• Childbirth

• Labour contractions

• Breastfeeding

• Mother-infant bonding

• Sexual reproduction

• Emotional attachment and social bonding

Although the body naturally produces oxytocin, pharmaceutical companies also manufacture a synthetic version that is chemically identical to the naturally occurring hormone.

Hospitals worldwide routinely use synthetic oxytocin during labour and after childbirth because it produces the same biological effects as natural oxytocin when administered correctly.

It is usually administered through:

• Intravenous (IV) infusion

• Intramuscular injection

The medicine is carefully stored under recommended temperature conditions because excessive heat or improper storage can reduce its effectiveness.

Why Is Oxytocin Given During a Caesarean Section?

Many people assume that once a baby has been delivered during surgery, the procedure is complete.

In reality, the moments immediately after delivery are among the most critical for protecting the mother's life.

After the baby and placenta are delivered, the uterus must contract firmly.

These contractions are vital because they compress the blood vessels that supplied the placenta during pregnancy.

If these blood vessels remain open, severe bleeding can occur within minutes.

During normal vaginal labour, the body releases large amounts of natural oxytocin in response to contractions and childbirth.

However, during a Caesarean section—particularly when performed under spinal or epidural anaesthesia—this natural hormonal response may be significantly reduced.

As a result, doctors routinely administer synthetic oxytocin immediately after the baby is delivered to ensure that the uterus contracts effectively.

Without adequate uterine contractions, the risk of excessive bleeding rises dramatically.

How Oxytocin Prevents Life-Threatening Bleeding

One of oxytocin's most important medical functions is preventing postpartum haemorrhage (PPH).

Postpartum haemorrhage refers to excessive bleeding after childbirth and remains one of the leading causes of maternal mortality across the world.

Following delivery, the placenta separates from the wall of the uterus.

This leaves behind numerous open blood vessels.

If the uterus contracts strongly, the muscle fibres naturally compress these blood vessels, limiting blood loss.

If the uterus remains soft or relaxed—a condition known medically as uterine atony—the blood vessels continue bleeding.

This can rapidly lead to:

• Massive blood loss

• Shock

• Organ failure

• Emergency hysterectomy

• Intensive care admission

• Maternal death

Oxytocin stimulates powerful uterine contractions that act as the body's natural bleeding control mechanism.

Understanding the "Natural Pressure Bandage" Analogy

Dr. Richa Bharadwaj, Consultant Obstetrician and Gynaecologist at Wockhardt Hospitals, Mumbai Central, explains oxytocin's role using a simple but powerful analogy.

She compares the uterus to a natural pressure bandage.

After childbirth, the blood vessels where the placenta was attached remain open.

Oxytocin causes the uterine muscles to tighten around these vessels.

This compression reduces blood flow naturally and helps stop excessive bleeding.

If the uterus fails to contract adequately, blood loss may become severe within a short period.

Such situations often require:

• Emergency medications

• Blood transfusions

• Intensive monitoring

• Additional surgery

• Critical care support

The analogy illustrates why oxytocin is considered indispensable during childbirth.

Oxytocin Supports More Than Bleeding Control

Although preventing haemorrhage is its primary purpose during delivery, oxytocin performs several additional functions.

It helps:

• Stimulate breast milk ejection during breastfeeding.

• Promote maternal-infant bonding.

• Assist in complete placental separation.

• Reduce retained placental tissue.

• Improve uterine recovery after childbirth.

These combined benefits make oxytocin one of the most widely used medicines in obstetrics worldwide.

What Happens If Oxytocin Does Not Work?

If oxytocin is ineffective, degraded, improperly stored, or lacks sufficient active ingredients, the uterus may fail to contract adequately.

The consequences can become serious within minutes.

Potential complications include:

• Persistent uterine relaxation

• Heavy postpartum bleeding

• Emergency blood transfusions

• Repeat surgery

• Intensive care admission

• Increased maternal mortality risk

Doctors may then need to administer additional uterotonic medicines or perform emergency interventions to control the bleeding.

Because postpartum haemorrhage develops rapidly, the quality and effectiveness of oxytocin are critically important.

Rajasthan Investigation: Why Is Fake or Substandard Oxytocin Under Suspicion?

The recent maternal health incidents in Rajasthan have brought attention to allegations involving fake or substandard oxytocin supplies.

According to preliminary investigations reported by authorities, certain batches of oxytocin used in some hospitals allegedly lacked the required active pharmaceutical ingredient.

If laboratory findings ultimately confirm these allegations, the medicine would have been unable to produce the uterine contractions necessary to control bleeding effectively.

Investigators are examining whether ineffective oxytocin contributed to excessive postpartum haemorrhage experienced by several women.

It is important to note that investigations remain ongoing, and the final findings will determine the precise causes of the reported complications.

What Are Fake and Substandard Medicines?

Although often used interchangeably in public discussion, counterfeit and substandard medicines are not identical.

Counterfeit Medicines

Counterfeit medicines deliberately misrepresent their identity, source, or contents.

They may contain:

• No active ingredient

• Incorrect ingredients

• Harmful substances

• Incorrect dosage

These medicines are produced fraudulently.

Substandard Medicines

Substandard medicines are genuine products that fail to meet required quality standards.

Possible reasons include:

• Manufacturing defects

• Poor quality control

• Incorrect formulation

• Improper storage

• Temperature exposure during transport

• Degradation over time

Unlike counterfeit medicines, substandard medicines may originate from legitimate manufacturers but fail quality testing.

Both categories pose serious risks to patient safety.

Why Medicine Quality Is Especially Critical for Oxytocin

Oxytocin is particularly sensitive to environmental conditions.

Medical experts note that the medicine requires proper cold-chain storage throughout manufacturing, transportation, and hospital distribution.

Exposure to excessive heat may reduce its potency before administration.

Because India experiences high temperatures across many regions, maintaining uninterrupted cold-chain logistics is essential for preserving oxytocin's effectiveness.

Hospitals must therefore ensure:

• Proper refrigeration

• Continuous temperature monitoring

• Timely stock replacement

• Quality assurance testing

• Procurement from authorised suppliers

Even minor failures within the supply chain may affect clinical outcomes.

How Hospitals Manage Postpartum Haemorrhage

Although oxytocin is considered the first-line medicine, hospitals follow comprehensive emergency protocols when excessive bleeding occurs.

Doctors rapidly assess:

• Blood pressure

• Pulse rate

• Blood loss

• Uterine contraction

• Placental completeness

• Blood clotting function

Treatment may involve:

• Additional uterotonic medicines

• Intravenous fluids

• Blood transfusions

• Surgical procedures

• Intensive care monitoring

Early recognition remains the single most important factor in improving survival.

Why the Rajasthan Cases Have National Significance

The Rajasthan incidents extend beyond a single medicine or one hospital.

They have raised broader questions regarding:

• Drug quality regulation

• Hospital procurement systems

• Cold-chain management

• Maternal health infrastructure

• Emergency obstetric care

• Regulatory oversight

• Pharmacovigilance systems

Because oxytocin is administered in millions of deliveries across India each year, ensuring its quality is a matter of national public health importance.

The investigations may ultimately lead to stronger quality-control mechanisms for essential medicines used during childbirth.

While medical experts continue to examine the role of oxytocin in the Rajasthan cases, the incidents have also drawn attention to the broader systems responsible for ensuring medicine safety in India.

From manufacturing standards and quality testing to barcode-based drug traceability and regulatory inspections, multiple institutions play a role in protecting patients from counterfeit and substandard medicines.

QR Code Medicine Tracking, CDSCO Action, and India's Fight Against Fake Medicines: What the Rajasthan Oxytocin Case Means for Patient Safety

The recent maternal health incidents in Rajasthan have not only highlighted the importance of safe Caesarean deliveries and effective oxytocin but have also drawn attention to a much larger public health challenge—the circulation of counterfeit and substandard medicines.

Every year, millions of patients across India depend on life-saving medicines whose effectiveness cannot be judged by appearance alone. Whether it is an antibiotic, vaccine, anti-cancer drug, or emergency obstetric medicine like oxytocin, the quality of every dose directly affects patient outcomes.

Recognising this challenge, the Government of India has strengthened regulatory oversight through digital tracking systems, stricter inspections, and tougher enforcement against poor-quality medicines.

The Rajasthan investigation is therefore not merely about one medicine but about strengthening the entire pharmaceutical supply chain.

How India Plans to Stop Fake Medicines Through QR Code-Based Drug Tracking

One of the biggest reforms introduced by the Central Government is the mandatory use of QR codes and barcodes on several categories of medicines.

The objective is simple:

Every medicine should be traceable from the manufacturer to the patient.

The Ministry of Health has directed that medicines falling under Schedule H2 of the Drugs Rules carry a unique barcode or QR code on the primary packaging or, where space is limited, on the secondary packaging.

Initially, this requirement covers several high-risk categories including:

• Vaccines

• Antimicrobial medicines

• Narcotic drugs

• Psychotropic medicines

• Anti-cancer medicines

• Other notified Schedule H2 medicines

How the QR Code System Works

Each QR code functions like a digital identity card for the medicine.

When scanned, it can provide critical information such as:

• Manufacturer's name

• Brand name

• Batch number

• Manufacturing date

• Expiry date

• Unique product identification number

• Licence details

This enables regulators, distributors, hospitals, pharmacies, and in many cases consumers to verify whether the medicine belongs to a genuine manufacturing batch.

If a counterfeit medicine enters the market, authorities can trace its movement more efficiently and identify the point where the supply chain was compromised.

Why Digital Drug Traceability Matters

Counterfeit medicines often resemble genuine products so closely that patients and even healthcare professionals cannot distinguish them through visual inspection.

A digital traceability system offers several advantages.

It helps:

• Detect fake medicines quickly.

• Reduce circulation of counterfeit drugs.

• Improve recall of defective batches.

• Strengthen supply chain transparency.

• Protect hospitals from unknowingly purchasing substandard medicines.

• Increase public confidence in pharmaceutical products.

As India's pharmaceutical market continues to expand, digital authentication is expected to become an increasingly important component of drug regulation.

CDSCO: India's National Drug Regulatory Authority

The agency responsible for regulating medicines at the national level is the Central Drugs Standard Control Organisation (CDSCO).

Operating under the Directorate General of Health Services in the Ministry of Health and Family Welfare, CDSCO serves as India's National Regulatory Authority (NRA).

It functions under the provisions of the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945.

While state drug regulators supervise manufacturing and distribution within their jurisdictions, CDSCO provides national coordination, technical expertise, and regulatory oversight.

Major Responsibilities of CDSCO

The organisation performs several critical functions within India's pharmaceutical regulatory framework.

These include:

Drug Approval

CDSCO evaluates new medicines before they can be marketed in India.

Manufacturers must demonstrate quality, safety, and efficacy through scientific evidence before approval is granted.

Clinical Trial Regulation

The authority reviews and supervises clinical trials involving new medicines to ensure compliance with ethical and scientific standards.

Drug Quality Standards

CDSCO develops and enforces quality standards that pharmaceutical products must satisfy before entering the Indian market.

Import Quality Control

Medicines imported into India undergo regulatory oversight to ensure compliance with Indian quality standards.

Coordination with State Drug Controllers

Since drug regulation is shared between the Centre and the States, CDSCO works closely with State Drug Control Organisations to maintain uniform enforcement across the country.

CDSCO's Investigation into the Rajasthan Oxytocin Case

Following reports of maternal deaths and complications in Rajasthan, CDSCO initiated a joint inspection along with state drug regulators.

Inspection teams visited manufacturing facilities of Jackson Laboratories, the manufacturer whose oxytocin batches came under scrutiny.

The inspections covered facilities located in:

• Punjab

• Himachal Pradesh

The objective was to examine:

• Manufacturing practices

• Quality control procedures

• Batch records

• Storage conditions

• Regulatory compliance

Authorities are continuing laboratory analysis and investigations before reaching final conclusions regarding the suspected batches.

Such investigations form an important part of India's pharmacovigilance and drug quality assurance system.

Strengthening India's Drug Quality Ecosystem

The Rajasthan incidents have reinforced the importance of maintaining quality assurance throughout the pharmaceutical supply chain.

Drug quality depends upon multiple interconnected stages:

• Manufacturing

• Quality testing

• Packaging

• Transportation

• Cold-chain management

• Storage

• Hospital procurement

• Distribution

• Administration

Failure at any stage may compromise patient safety.

For temperature-sensitive medicines such as oxytocin, maintaining uninterrupted cold-chain storage is particularly critical because exposure to excessive heat can reduce potency.

Hospitals, distributors, and manufacturers therefore share responsibility for preserving medicine quality until it reaches the patient.

Government Tightens Regulation of Fixed Dose Combination (FDC) Medicines

The Centre has also taken broader steps to improve medicine safety.

Recently, the Ministry of Health and Family Welfare prohibited the manufacture, sale, and distribution of 16 Fixed Dose Combination (FDC) medicines under Section 26A of the Drugs and Cosmetics Act.

Fixed Dose Combination medicines contain two or more active pharmaceutical ingredients within a single dosage form.

Although many FDCs provide genuine therapeutic benefits, some combinations have raised concerns regarding:

• Safety

• Effectiveness

• Scientific justification

• Potential adverse effects

Why Were Certain FDC Medicines Banned?

The latest action follows a detailed review initiated after directions issued by the Supreme Court.

Based on these directions, CDSCO's Drugs Technical Advisory Board (DTAB) constituted an expert committee to evaluate numerous fixed-dose combinations available in the Indian market.

After scientific evaluation, certain formulations were found to pose greater risks than benefits.

Consequently, the Government exercised its powers under Section 26A of the Drugs and Cosmetics Act to prohibit these medicines in the interest of public health.

The decision demonstrates the evolving regulatory approach toward ensuring that medicines sold in India remain both safe and scientifically justified.

Lessons from the Rajasthan Maternal Health Investigation

Although the investigation into the Rajasthan maternal deaths is still ongoing, several important lessons have already emerged.

The incidents underline the importance of:

• High-quality essential medicines.

• Strict regulatory oversight.

• Efficient hospital procurement systems.

• Proper cold-chain maintenance.

• Timely laboratory testing.

• Continuous pharmacovigilance.

• Strong inspection mechanisms.

• Transparent reporting of adverse events.

Together, these measures form the backbone of patient safety in modern healthcare systems.

Why This Story Matters Beyond Rajasthan

The issues highlighted by the Rajasthan cases extend well beyond one state.

India performs millions of institutional deliveries every year, and medicines such as oxytocin are administered routinely in hospitals across the country.

Ensuring that every dose is safe, effective, and properly stored is essential not only for maternal health but also for maintaining public confidence in the healthcare system.

The Government's recent initiatives—including QR-code drug traceability, stronger inspections, enhanced regulatory coordination, and scientific review of medicines—represent important steps toward reducing the circulation of counterfeit and substandard medicines.

If implemented consistently, these reforms can strengthen India's pharmaceutical supply chain and improve patient safety nationwide.

The Rajasthan maternal health incidents have drawn national attention to two equally important realities.

First, medicines such as oxytocin remain indispensable for preventing life-threatening complications during childbirth and saving mothers' lives.

Second, the effectiveness of these medicines depends on rigorous manufacturing standards, proper storage, efficient regulation, and continuous quality monitoring.

Through investigations by CDSCO, mandatory QR-code-based drug traceability, stronger enforcement under the Drugs and Cosmetics Act, and ongoing reforms in pharmaceutical regulation, India is attempting to build a safer healthcare ecosystem.

While investigations into the Rajasthan cases continue, the episode serves as a reminder that protecting maternal health requires more than skilled doctors and modern hospitals. It also depends on reliable medicines, transparent regulation, robust supply chains, and a healthcare system capable of identifying and responding quickly to any threat to patient safety.

Ultimately, safeguarding the quality of essential medicines is not only a regulatory responsibility but also a public health imperative that directly affects millions of patients and families across the country.

---

Frequently Asked Questions (FAQs)

Q. Why is oxytocin given after a Caesarean (C-section) delivery?

Answer. Oxytocin is routinely administered after a Caesarean section to help the uterus contract immediately after the baby is delivered. These contractions compress the blood vessels where the placenta was attached, significantly reducing blood loss and lowering the risk of postpartum haemorrhage (PPH), one of the leading causes of maternal deaths worldwide. Oxytocin also helps expel the placenta and supports early breastfeeding by stimulating milk let-down.

Q. What are the most common complications after a Caesarean section?

Answer. Most women recover safely after a C-section, but complications can occur. Common complications include surgical site infections, heavy bleeding (postpartum haemorrhage), reactions to anaesthesia, blood clots, injury to nearby organs such as the bladder or intestines, delayed wound healing, and longer recovery compared to vaginal delivery. Early diagnosis and proper medical care usually prevent serious outcomes.

Q. What is postpartum haemorrhage (PPH), and why is it dangerous?

Answer. Postpartum haemorrhage (PPH) is excessive bleeding after childbirth and is one of the leading causes of maternal mortality worldwide. It usually occurs when the uterus fails to contract properly after delivery, leaving blood vessels open where the placenta was attached. Immediate treatment with medicines like oxytocin, intravenous fluids, blood transfusions, or surgery may be required to save the mother's life.

Q. What is oxytocin, and how does it help during childbirth?

Answer. Oxytocin is a naturally occurring hormone produced by the pituitary gland. During childbirth, it stimulates uterine contractions that help deliver the baby and reduce bleeding after delivery. Hospitals also administer a synthetic form of oxytocin during labour and Caesarean sections to induce labour, prevent postpartum haemorrhage, assist in placental delivery, and support breastfeeding.

Q. How can fake or substandard oxytocin affect mothers after delivery?

Answer. If oxytocin lacks the required active ingredient or has deteriorated due to poor manufacturing or storage, it may fail to produce adequate uterine contractions. This can increase the risk of severe postpartum bleeding, emergency blood transfusions, intensive care admission, and maternal death. This is one of the reasons why drug quality and proper cold-chain storage are critical.

Q. Why are QR codes being introduced on medicines in India?

Answer. The Government of India has mandated QR codes or barcodes on several categories of medicines to improve traceability and prevent counterfeit drugs from entering the supply chain. Scanning the QR code can help verify details such as the manufacturer, batch number, manufacturing date, expiry date, and product identification, making it easier to identify genuine medicines and recall defective batches.

Q. What is the role of the Central Drugs Standard Control Organisation (CDSCO)?

Answer. The Central Drugs Standard Control Organisation (CDSCO) is India's national drug regulatory authority under the Ministry of Health and Family Welfare. It is responsible for approving new drugs, regulating clinical trials, setting drug quality standards, monitoring imported medicines, coordinating with State Drug Control Organisations, and ensuring compliance with the Drugs and Cosmetics Act, 1940.

Q. How can pregnant women reduce the risk of complications during a Caesarean delivery?

Answer. Pregnant women can reduce risks by attending regular antenatal check-ups, following medical advice, choosing accredited healthcare facilities, discussing delivery plans with their obstetrician, informing doctors about existing medical conditions or allergies, and seeking immediate medical attention if they experience fever, excessive bleeding, severe pain, or abnormal wound discharge after delivery.

Q. Why is maternal healthcare still a major public health challenge in India?

Answer. Although India has significantly reduced maternal mortality over the past two decades, challenges remain due to postpartum haemorrhage, infections, delayed emergency care, shortages of trained healthcare professionals, medicine quality issues, and unequal access to advanced medical facilities. Strengthening trauma care, emergency obstetric services, and drug quality regulation remains essential to improving maternal health outcomes.

Q. What lessons can be learned from the Rajasthan maternal health incidents?

Answer. The Rajasthan incidents highlight the importance of high-quality medicines, strict regulatory oversight, timely diagnosis of postpartum complications, proper storage of temperature-sensitive drugs like oxytocin, well-equipped hospitals, and effective monitoring systems. They also underscore the need for continuous inspections, transparent investigations, and stronger patient safety measures to prevent avoidable maternal deaths.